IDEAS home Printed from https://ideas.repec.org/a/jns/jbstat/v227y2007i5-6p787-805.html
   My bibliography  Save this article

Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany?

Author

Listed:
  • Schulenburg J.-Matthias Graf von der
  • Vauth Christoph

    (Forschungsstelle für Gesundheitsökonomie und Gesundheitssystemforschung, Leibniz Universität Hannover, Königsworther Platz 1, 30167 Hannover, Germany)

Abstract

The paper presents the methodological challenges of the introduction of cost-benefit assessment by the German legislative (Competition Enhancement Act). Based on the standards for health economic evaluation accepted by the international scientific health economic community, this paper provides a minimum catalogue of methods and criteria to meet the legal German requirements. The methodological framework presented in this paper discusses the perspective to be used to evaluate cost and benefits, lists the appropriate study form, names the usage of primary or secondary data, the description of the cost and benefit calculation, shows the specific need on modelling and how to handle uncertainties and calls for a disclosure of potential conflict of interests.

Suggested Citation

  • Schulenburg J.-Matthias Graf von der & Vauth Christoph, 2007. "Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany?," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 227(5-6), pages 787-806, October.
    • Handle: RePEc:jns:jbstat:v:227:y:2007:i:5-6:p:787-805
    DOI: 10.1515/jbnst-2007-5-621
    as

    Download full text from publisher

    File URL: https://doi.org/10.1515/jbnst-2007-5-621
    Download Restriction: no
    File URL: https://libkey.io/10.1515/jbnst-2007-5-621?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Meltzer, David, 2001. "Addressing uncertainty in medical cost-effectiveness analysis: Implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to s," Journal of Health Economics, Elsevier, vol. 20(1), pages 109-129, January.
    2. Murray, Christopher J. L. & Acharya, Arnab K., 1997. "Understanding DALYs," Journal of Health Economics, Elsevier, vol. 16(6), pages 703-730, December.
    3. repec:spr:pharme:v:19:y:2001:i:6:p:609-621 is not listed on IDEAS
    4. Mark J. Sculpher & Karl Claxton & Mike Drummond & Chris McCabe, 2006. "Whither trial‐based economic evaluation for health care decision making?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 677-687, July.
    5. Uwe Siebert, 2003. "When should decision-analytic modeling be used in the economic evaluation of health care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 143-150, September.
    6. Jonathan Karnon, 2003. "Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation," Health Economics, John Wiley & Sons, Ltd., vol. 12(10), pages 837-848, October.
    7. Anand, Sudhir & Hanson, Kara, 1997. "Disability-adjusted life years: a critical review," Journal of Health Economics, Elsevier, vol. 16(6), pages 685-702, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. James A. Hall & Kika Konstantinou & Martyn Lewis & Raymond Oppong & Reuben Ogollah & Sue Jowett, 2019. "Systematic Review of Decision Analytic Modelling in Economic Evaluations of Low Back Pain and Sciatica," Applied Health Economics and Health Policy, Springer, vol. 17(4), pages 467-491, August.
    2. Kimberly M. Thompson, 2002. "Data Requirements for Valuation of Children’s Health Effects and Alternatives to Valuation," NCEE Working Paper Series 200206, National Center for Environmental Economics, U.S. Environmental Protection Agency, revised Sep 2002.
    3. Mitchell, Shannon K., 2004. "Death, Disability, Displaced Persons and Development: The Case of Landmines in Bosnia and Herzegovina," World Development, Elsevier, vol. 32(12), pages 2105-2120, December.
    4. Skordis, Jolene & Nattrass, Nicoli, 2002. "Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa," Journal of Health Economics, Elsevier, vol. 21(3), pages 405-421, May.
    5. Barrientos, Armando & Gorman, Mark & Heslop, Amanda, 2003. "Old Age Poverty in Developing Countries: Contributions and Dependence in Later Life," World Development, Elsevier, vol. 31(3), pages 555-570, March.
    6. Jensen Jørgen Dejgaard & Mørkbak Morten Raun & Nordström Jonas, 2012. "Economic Costs and Benefits of Promoting Healthy Takeaway Meals at Workplace Canteens," Journal of Benefit-Cost Analysis, De Gruyter, vol. 3(4), pages 1-29, December.
    7. J.- Graf v. d. Schulenburg & Christoph Vauth & Thomas Mittendorf & Wolfgang Greiner, 2007. "Methods for determining cost-benefit ratios for pharmaceuticals in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(1), pages 5-31, September.
    8. Edward C. Mansley & Elamin H. Elbasha, 2003. "Preferences and person trade‐offs: forcing consistency or inconsistency in health‐related quality of life measures?," Health Economics, John Wiley & Sons, Ltd., vol. 12(3), pages 187-198, March.
    9. Armando Barrientos, 2002. "Old age, poverty and social investment," Journal of International Development, John Wiley & Sons, Ltd., vol. 14(8), pages 1133-1141.
    10. Mara Airoldi & Alec Morton, 2009. "Adjusting life for quality or disability: stylistic difference or substantial dispute?," Health Economics, John Wiley & Sons, Ltd., vol. 18(11), pages 1237-1247, November.
    11. Marcello Basili & Filippo Belloc, 2015. "How To Measure The Economic Impact Of Vector-Borne Diseases At Country Level," Journal of Economic Surveys, Wiley Blackwell, vol. 29(5), pages 896-916, December.
    12. Marcello Basili & Filippo Belloc, 2012. "How to Measure the Economic Impact of Vector-Borne Diseases at a Country Level: An Assessment," Department of Economics University of Siena 648, Department of Economics, University of Siena.
    13. Dixon, Padraig & Harrison, Sean & Hollingworth, William & Davies, Neil M. & Davey Smith, George, 2022. "Estimating the causal effect of liability to disease on healthcare costs using Mendelian Randomization," Economics & Human Biology, Elsevier, vol. 46(C).
    14. Erik Nord, 2001. "The desirability of a condition versus the well being and worth of a person," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 579-581, October.
    15. Carl Lyttkens, 2003. "Time to disable DALYs?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 195-202, September.
    16. Elamin H. Elbasha, 2000. "Discrete time representation of the formula for calculating DALYs," Health Economics, John Wiley & Sons, Ltd., vol. 9(4), pages 353-365, June.
    17. Francisco J. Díez & Mar Yebra & Iñigo Bermejo & Miguel A. Palacios-Alonso & Manuel Arias Calleja & Manuel Luque & Jorge Pérez-Martín, 2017. "Markov Influence Diagrams," Medical Decision Making, , vol. 37(2), pages 183-195, February.
    18. Lois G. Kim & Simon G. Thompson, 2010. "Uncertainty and validation of health economic decision models," Health Economics, John Wiley & Sons, Ltd., vol. 19(1), pages 43-55, January.
    19. Charles F Manski, 2007. "Adaptive Minimax-Regret Treatment Choice, with Application to Drug Approval," Levine's Working Paper Archive 122247000000001404, David K. Levine.
    20. Lih-Wen Mau & Jaime M. Preussler & Linda J. Burns & Susan Leppke & Navneet S. Majhail & Christa L. Meyer & Tatenda Mupfudze & Wael Saber & Patricia Steinert & David J. Vanness, 2020. "Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach," PharmacoEconomics, Springer, vol. 38(5), pages 515-526, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:jns:jbstat:v:227:y:2007:i:5-6:p:787-805. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.